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To the Editor
Tissue deposition of soluble autologous proteins as insoluble
amyloid ®brils is associated with a range of serious diseases
including Alzheimer's disease, the transmissible spongiform en-
cephalopathies (prion diseases), and systemic amyloidosis (Glenner,
1980; Kisilevsky, 1998). Although yellow or brownish skin amyloid
plaques have been described in several different types of systemic
amyloidosis (Touart and Sau, 1998; Asl et al, 1999), the
chromophore responsible for this yellowish hue has not been
identi®ed to date. We have used high-performance liquid
chromatography (HPLC) to analyze for the ®rst time such colored
skin lesions ex vivo. We found a selective accumulation of the
xanthophyll lutein in skin amyloid deposits of a patient with
systemic amyloidosis suggesting the participation of a naturally
occurring carotenoid in the pathogenesis of amyloidosis in vivo.
In our patient, an 86-y-old female, amyloidosis was associated
with a clonal plasma cell dyscrasia caused by multiple myeloma
(Touart et al, 1998). A de®ning characteristic of this serious and
usually fatal type of systemic amyloidosis are amyloid proteins
derived from immunoglobulin light chains (amyloid L, AL).
Histologic examination of lesional skin specimens from our patient
(Fig 1a) revealed prominent amyloid deposits that displayed green
birefringence with Congo red stain throughout the dermis (Fig 1b).
The ultrastructural appearance of these amyloid ®brils is demon-
strated in Fig 1(c).
For reversed-phase HPLC, tissue and plasma carotenes were
extracted and separated as previously described (Wingerath et al,
1999). A selective 60-fold elevation in lutein concentration was
detected in skin lesions of our patient (Fig 1d). The mean lutein
concentration was 6 nmol per g in lesional skin tissue and 0.1 nmol
per g in nonlesional tissue. In contrast, plasma concentration of
lutein was within normal limits (0.29 nmol per ml) indicating that
the binding of lutein to skin amyloid deposits is speci®c.
Yellow color of the skin can be due to the presence of several
physiologically occurring colored compounds such as bilirubin or
carotenoids. In contrast to carotene icterus, a typical symptom after
high dietary intake of b-carotene, lutein-caused coloration of the
skin has not been described so far. Lutein is a micronutrient that is
not formed in the metabolism of humans but can be found in dark
green vegetables (e.g., kale, collards, mustard greens) and yellow or
orange fruits. This carotenoid can inactivate electronically excited
molecules and participate in free radical reactions (Schalch et al,
1999; Wingerath et al, 1999).
It has lately been shown that the macula lutea (Latin for yellow
spot) acquires its color because the retina accumulates lutein and its
structural isomer zeaxanthin from the diet via the plasma. Both
carotenoids are radical scavengers and thought to protect primate
retinas against damage by light and against risk of severe vision loss
from age-related macular degeneration (Schalch et al, 1999).
Previously, we described the use of reversed-phase HPLC to
separate and assign carotenol fatty acid esters in human skin
(Wingerath et al, 1999). Here, we show the selective accumulation
of the xanthophyll lutein, a major parent carotenol, in skin amyloid
plaques of a patient with systemic amyloidosis. Emerging from our
®ndings is the idea that amyloid ®brils avidly and selectively bind
the naturally occurring carotenoid lutein in vivo, because we found
extraordinarily high amounts of lutein in lesional skin only, but not
in normal skin or in the blood. Our patient did not eat a special
lutein-rich diet, indicating that the accumulation of lutein was not
induced by an alimentary excess of the carotenoid. The abundance
of lutein in amyloid deposits relative to its trace concentration in
nonlesional skin tissue and in the plasma is remarkable and argues
against a direct binding of lutein to the monoclonal immunoglo-
bulins formed by the myeloma cells.
Our case thus clearly indicates a speci®c interaction of the
naturally occurring carotenoid lutein with amyloid ®brils in vivo.
There is considerable evidence that oxidative stress exerted by
inappropriate deposition of amyloid ®brils can affect signal
transduction pathways, and result in cytotoxicity (Kisilevsky,
Figure 1.Accumulation of lutein in skin amyloid deposits. (a) A characteristic waxy yellow-orange amyloid plaque on the upper trunk of a patient
with systemic amyloidosis. Purpura is a hallmark of plaque-associated amyloid angiopathy. (b) Micrograph of a skin amyloid plaque displaying green
birefringence of Congo red-stained amyloid deposits (arrows) under polarized light. (c) Ultramicrographs of skin amyloid deposits (s) surrounding small
lymphatic (r) and blood (*) vessels (inset: ®brillary architecture of amyloid deposits). (d) HPLC separation of tissue carotenoids in our amyloidosis patient:
signi®cantly more lutein is present in lesional skin tissue (mean lutein concentration: 6 nmol per g, top) than in nonlesional tissue (0.1 nmol per g, bottom).
Correspondingly low lutein levels were observed in normal skin of a control person (data not shown). Scale bars: (a) 1 cm; (b) 500 mm; (c) 5 mm.
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1998). Consequently, an inescapable facet of linking the accumula-
tion of lutein to amyloid pathology is the modulation of deleterious
amyloid effects by the protective radical-scavenging potential of
lutein. Further experimental elucidation of the role of lutein in
amyloid deposits may provide new insight into amyloid-associated
pathology with potentially important therapeutic implications.
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